When the human genome draft was announced 10 years ago, many researchers and policymakers anticipated using the newly sequenced code to develop a wealth of diagnostic and treatment capabilities. But the genetic components of disease have proved more complex
June 24, 2010 |
Even as scans get faster and cheaper, many diseases still have unknown or sketchy genetic correlates. How much stock should consumers put in personal genome sequencing?
A new breed of vaccine is being developed that will make possible immunizations tailored to your genetic profile. But how long will it be until your personalized booster shots are ready?
As researchers learn more about genetic profile of various cancers, other work is charging ahead to deliver personalized vaccines targeted to a patient's own tumor cells
Commentary on the 10th anniversary of the human genome draft by Francis Collins, director of the National Institutes of Health
Deadline: Jul 15 2013
Reward: $5,000 USD
SciBX: Science-Business eXchange, a joint publication from the makers
Deadline: Jun 30 2013
Reward: $1,000,000 USD
This is a Reduction-to-Practice Challenge that requires written documentation and&
Save 66% off the cover price and get a free gift!
Learn More >>X